Shares of Hims & Hers Health Inc. ($HIMS) have experienced notable fluctuations recently. The stock was among the top three gainers year-to-date, trading around $54 with a forward price-to-earnings ratio of approximately 35 to 40, supported by consistent earnings beats. However, the stock has softened in recent days, including a decline of about $4, potentially linked to selling by fast money investors reallocating funds to the Hinge IPO. Over the past four trading sessions, $HIMS has posted consecutive declines accompanied by above-average trading volume. Market observers suggest the stock could fall to the mid to high $30 range amid this volatility.
$HIMS just had 4 red days in a row with today being on above average volume. Not my first rodeo with this stock. If you see mid to high 30's do not be surprised.
Is $HIMS down $4 because the fast money holders sold stock to fund Hinge IPO???
$HIMS has gone limp https://t.co/vLjlmTRSA1